Beloved children’s book character likely lost sight from viral meningoencephalitis, research highlights how tales of disease influence perception of disease.
Visual symptoms and abnormalities occur at high rates in people with traumatic brain injury (TBI)—including Iraq and Afghanistan War veterans with blast-related TBI, reports a study, “Abnormal Fixation in Individuals with AMD when Viewing an Image of a Face”, in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.
Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Now, new research from the Scheie Eye Institute, published this week in the Proceedings of the National Academy of Sciences, finds that gene therapy for LCA shows enduring improvement in vision but also advancing degeneration of affected retinal cells, both in LCA patients and animal models of the same condition.
Researchers at The Ohio State University are developing a new glaucoma test that would catch the blindness-causing disease earlier and more accurately than current tests that rely on human input.
Melanomas that develop in the eye often are fatal. Now, scientists at Washington University School of Medicine in St. Louis report they have identified a mutated gene in melanoma tumors of the eye that appears to predict a good outcome.
A new Investigative Ophthalmology & Visual Science (IOVS) article reveals that increasingly aggressive therapies that block VEGF could cause damage in treating eye diseases. Scientists discovered inhibiting anti-VEGF might have a harmful effect on the tissue responsible for producing the fluid that bathes the eye, medically termed the ciliary body.
We rely on our visual system more heavily than previously thought in determining the causality of events. A team of researchers has shown that, in making judgments about causality, we don’t always need to use cognitive reasoning. In some cases, our visual brain—the brain areas that process what the eyes sense—can make these judgments rapidly and automatically.
Abnormalities of eye movement and fixation may contribute to difficulty in perceiving and recognizing faces among older adults with age-related macular degeneration (AMD), suggests a study “Abnormal Fixation in Individuals with AMD when Viewing an Image of a Face” appearing in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A new study finds that certain changes in blood vessels in the eye’s retina can be an early warning that a person is at increased risk for glaucoma, an eye disease that slowly robs people of their peripheral vision. Using diagnostic photos and other data from the Australian Blue Mountains Eye Study, the researchers showed that patients who had abnormally narrow retinal arteries when the study began were also those who were most likely to have glaucoma at its 10-year end point. If confirmed by future research, this finding could give ophthalmologists a new way to identify and treat those who are most vulnerable to vision loss from glaucoma. The study was recently published online by Ophthalmology, the journal of the American Academy of Ophthalmology.
Two recent experimental treatments — one involving skin-derived induced pluripotent stem (iPS) cell grafts, the other gene therapy — have been shown to produce long-term improvement in visual function in mouse models of retinitis pigmentosa (RP), according to the Columbia University Medical Center scientists who led the studies. At present, there is no cure for RP, the most common form of inherited blindness.
People who regularly took aspirin 10 years prior to examination had a small but statistically significant increase in the risk of a subtype of age-related macular degeneration (AMD), according to a study by University of Wisconsin-Madison researchers.
A new study published in Investigative Ophthalmology & Visual Science found that between 40 to 50 percent of older adults with visually impairing eye disease limit their activities due to a fear of falling. Vision scientists warn that this protective strategy puts seniors at risk for social isolation and disability.
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor
Better strategies are needed to help glaucoma patients cope with difficulty reading. According to a new scientific study published in Investigative Ophthalmology & Visual Science, adults with glaucoma read slower when reading silently for long periods of time and are more likely to have their reading speed decrease over time, possibly a result of reading fatigue.
For people using 30-day extended-wear/continuous-wear (EW/CW) contact lenses, replacing lenses at night doesn't lower the risk of complications compared to changing lenses monthly, suggests a study – “The Effect of Daily Lens Replacement During Overnight Wear on Ocular Adverse Events”, appearing in the December issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Working with mice, Johns Hopkins researchers have shed light on the activity of a protein pair found in cells that form the walls of blood vessels in the brain and retina, experiments that could lead to therapeutic control of the blood-brain barrier and of blood vessel growth in the eye.
With the holiday season upon us, children are busy making their wish lists and checking them twice. But, parents may need to check them yet again to ensure toy safety. According to the U.S. Consumer Product Safety Commission, more than 250,000 toy-related injuries are treated in emergency rooms each year. Most of these injuries affect children under age 15, and almost half affect the head or face. In light of these dangers, the American Academy of Ophthalmology encourages parents to be EyeSmart about toys this holiday season.
A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to year-one clinical trial results for the device. Results of the HYDRUS I clinical trial, which indicate successful control of eye pressure in all study participants, will be presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
New research shows that the use of an audio therapy known as binaural beats can significantly reduce patients’ anxiety during cataract surgery. The 141-patient study, conducted in Thailand, is the first of its kind in cataract surgery, which is one of the most frequently performed procedures worldwide, with more than 3 million performed annually in the United States. The research is being presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
A new study provides the first clear evidence that vision or eye problems are rarely the cause of recurring headaches in children, even if the headaches usually strike while the child is doing schoolwork or other visual tasks. Many parents assume that frequent headaches mean their child needs glasses, so they ask their doctor to refer their child for an eye exam. This study was conducted by pediatric ophthalmologists who wanted to find reliable answers for parents, family doctors and pediatricians facing this common health question. The research is being presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, conducted jointly this year with the Asia-Pacific Academy of Ophthalmology.
The first study to compare accident rates for drivers who have advanced glaucoma − an eye disease that affects peripheral vision − with normal-vision drivers, found that the glaucoma group had about twice as many accidents. This study, which was conducted in Japan using a driving simulator, suggests that potential drivers should pass a visual field test to ensure adequate peripheral vision before a license is granted or renewed.
People who have eye diseases that damage their central vision can regain the ability to read quickly and comfortably by using digital tablets, according to a recent study. The research found that people with moderate vision loss could increase their reading speed by 15 words-per-minute, on average. Using a tablet with a back-lit screen resulted in the fastest reading speeds for all study participants, no matter what their level of visual acuity
Many veterans of the United States armed forces who have traumatic brain injury or post-traumatic stress disorder also have undiagnosed, chronic vision problems, according to two studies presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
The primary treatment for wet macular degeneration, a chronic eye condition that causes vision loss, is effective even if patients have macular traction problems, a Mayo Clinic study shows.
For the first time, Wisconsin researchers have taken skin from patients and, using induced pluripotent stem cell (iPSC) technology, turned them into a laboratory model for an inherited type of macular degeneration.
Modern contact lens materials are prone to drying when exposed to air, which contributes to the buildup of deposits on contact lenses, according to a study – “The Impact of Intermittent Air Exposure on Lipid Deposition”, appearing in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Decorative tinted contact lenses will be popular accessories this Halloween, but a Loyola University Medical Center optometrist is warning that improper use without a prescription could cause severe eye damage.
Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in the world.
Researchers at Missouri University of Science and Technology are working with an antioxidant that could prevent or cure cataracts, macular degeneration and other degenerative eye disorders.
Perelman School of Medicine researchers at the University of Pennsylvania have created a map of vision in the brain based upon an individual's brain structure, even for people who cannot see. Their result can, among other things, guide efforts to restore vision using a neural prosthesis that stimulates the surface of the brain.
A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide
A simple test of eyelid sensitivity may help vision professionals in evaluating one of the most common eye-related symptoms: dry eyes. A new study linking increased eyelid sensitivity to decreased function of the eyelid margins is presented in the article – “Lid Margins: Sensitivity, Staining, Meibomian
Gland Dysfunction, and Symptoms”, appearing in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
An experimental treatment for blindness, developed from a patient’s skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
A small subset of patients account for a large proportion of all glaucoma-related charges in the U.S., according to new data. These findings have importance for future evaluations of the cost-effectiveness of screening and treatment for glaucoma.
Millions of Americans have poor vision that can't be corrected by conventional glasses or contact lenses. But many of them can benefit from new techniques to maximize their residual vision and thus enhance their daily living and mobility, according to a study – “The Berkeley Rudimentary Vision Test (BRVT)”, in the special September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Clinical trials can be time-consuming, expensive and intrusive, but they are also necessary. Researchers at the University of Tennessee Space Institute in Tullahoma have developed an invention that makes clinical trials more efficient by moving them into the virtual world.
Eighty-five percent of children's learning is related to vision. Yet in the U.S., 80 percent of children have never had an eye exam or any vision screening before kindergarten, statistics say. When they do, the vision screenings they typically receive can detect only one or two conditions.
A new treatment available at the University of Michigan Kellogg Eye Center provides relief to patients who suffer from severe dry eye, often the result of cancer or complex corneal disease.
Arizona State University kicks off a pilot program called 3D-IMAGINE (Image Arrays to Graphically Implement New Education), using three-dimensional materials to enhance independent learning by blind or visually-impaired students.
Shree Kurup, M.D., director of research in the ophthalmology department at Wake Forest Baptist Medical Center, will present the preliminary findings of a Phase 3 clinical trial on a new drug for the treatment of uveitis, a serious inflammatory condition of the uvea, the middle layer of the eye that provides most of the blood supply to the retina. The findings will be presented at the annual meeting of the American Society of Retinal Specialists in Las Vegas from Aug. 25 to 29.
For the first time, researchers decipher the retina’s neural code for brain communication to create novel, more effective prosthetic retinal device for blindness.